Infirmu: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Infirmu
Largest movements
- Cash +€18,439
up €18,439 (+1245.9%), from €1,480 to €19,919
mainly Other debts (+€18,000) and Net result for the year (+€9,491)
- Receivables within one year -€6,289
down €6,289 (-20.7%), from €30,415 to €24,126
of which Other amounts receivable: -€8,054
- Other debts +€18,000
new in 2025: €18,000
- Reserves -€12,000
down €12,000 (-60.4%), from €19,860 to €7,860
- Tax, wage and social debts +€3,830
new in 2025: €3,830
- Profit (loss) carried forward +€3,492
up €3,492, from -€2,375 to €1,117
- Trade debts -€1,238
down €1,238 (-55.1%), from €2,248 to €1,010
- Gross operating margin +€12,746
up €12,746, from -€734 to €12,012
- Taxes +€2,459
up €2,459 (+328.3%), from €749 to €3,208
- Other operating charges -€263
down €263 (-88.0%), from €299 to €36
- Financial income -€201
down €201 (-19.3%), from €1,042 to €841
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €32,133 | €44,217 | +€12,084 | +37.6% |
| Current assets | 29/58 | €32,133 | €44,217 | +€12,084 | +37.6% |
| Amounts receivable within one year | 40/41 | €30,415 | €24,126 | -€6,289 | -20.7% |
| Trade receivables | 40 | €10,235 | €12,000 | +€1,765 | +17.2% |
| Other amounts receivable | 41 | €20,180 | €12,126 | -€8,054 | -39.9% |
| Cash at bank and in hand | 54/58 | €1,480 | €19,919 | +€18,439 | +1245.9% |
| Deferred charges and accrued income | 490/1 | €238 | €172 | -€66 | -27.7% |
| Total equity and liabilities | 10/49 | €32,133 | €44,217 | +€12,084 | +37.6% |
| Equity | 10/15 | €29,885 | €21,377 | -€8,508 | -28.5% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €19,860 | €7,860 | -€12,000 | -60.4% |
| Distributable reserves | 133 | €19,860 | €7,860 | -€12,000 | -60.4% |
| Profit (loss) carried forward | 14 | -€2,375 | €1,117 | +€3,492 | |
| Amounts payable | 17/49 | €2,248 | €22,840 | +€20,592 | +916.0% |
| Amounts payable within one year | 42/48 | €2,248 | €22,840 | +€20,592 | +916.0% |
| Trade debts | 44 | €2,248 | €1,010 | -€1,238 | -55.1% |
| Suppliers | 440/4 | €2,248 | €1,010 | -€1,238 | -55.1% |
| Taxes, remuneration and social security | 45 | - | €3,830 | +€3,830 | |
| Taxes | 450/3 | - | €3,830 | +€3,830 | |
| Other amounts payable | 47/48 | - | €18,000 | +€18,000 | |
| Other operating charges | 640/8 | €299 | €36 | -€263 | -88.0% |
| Gross operating margin | 9900 | -€734 | €12,012 | +€12,746 | |
| Operating profit (loss) | 9901 | -€1,033 | €11,976 | +€13,009 | |
| Financial income | 75/76B | €1,042 | €841 | -€201 | -19.3% |
| Recurring financial income | 75 | €1,042 | €841 | -€201 | -19.3% |
| Financial charges | 65/66B | €165 | €118 | -€47 | -28.5% |
| Recurring financial charges | 65 | €165 | €118 | -€47 | -28.5% |
| Profit (loss) for the period before taxes | 9903 | -€156 | €12,699 | +€12,855 | |
| Income taxes | 67/77 | €749 | €3,208 | +€2,459 | +328.3% |
| Profit (loss) for the period | 9904 | -€905 | €9,491 | +€10,396 | |
| Profit (loss) for the period to be appropriated | 9905 | -€905 | €9,491 | +€10,396 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.